In this study, we aimed to analyze NSCLC for the expression of tumor PD-L1 and HLA-I in association with the pattern of immune cell infiltration to identify prognostic and predictive markers of cancer progression and response to immunotherapy. The gene discussed is CD274; the disease is neoplasm.